EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Translational research in viral hepatitis: Addressing the gaps for cure

 

23-25 January,2020 Athens
Close
N. Poster
Poster title
Applicant name
Status
  P02-01 Efficacy and safety of elbasvir/grazoprevir treatment in treatment-experienced and co-morbid HCV GT1b patients Pavel Bogomolov Received Received
  P01-01 Filling the gaps: HCV treatment at a needle exchange program in Sweden (project Actionne) Marianne Alanko Received Received
  P06-01 Metabolic programming of exhausted CD8 T cells in chronic viral hepatitis Frances Winkler Received Received
  P04-01 The role of sphingolipids as potential biomarkers of failure to direct acting antiviral therapy in chronic HCV infection Aissa Rhrig Received Received
  P05-01 Targeting hepatitis B virus with CRISPR/Cas9 Maria Guadalupe Martinez Received Received
  P03-01 Therapy of hepatitis C in people who inject drugs: focus on adherence Sona Frankova Received Received
  P04-02 Hepatitis C virus dysregulates polyamine and proline metabolism and perturbs urea cycle Alexander Ivanov Received Received
  P05-02 Reaching people who inject drugs most in need for HCV testing, diagnosis and linkage to care through a community-based program in Athens, Greece (ARISTOTLE HCV-HIV) Sotiris Roussos Received Received
  P02-02 hepatitis e virus infection among people living with hiv / aids virus in kano state Lawal Dahiru Received Received
  P06-02 A transient early HBV DNA increase during PEG-IFNa therapy of hepatitis D is associated with subsequent HDV RNA response and HBsAg loss Olympia Anastasiou Received Received
  P03-02 Development of Bipolymer based novel Nanoparticles in Microsphere system as vaccine adjuvant Prakash Gosain Received Received
  P01-02 Development and Characterization of Oral combination vaccine against Hepatitis B and Influenza Mani Bhargava Received Received
  P04-03 HCV course, efficacy and safety of DAA treatment in patients with inherited blood disorders Abdourahman Jallow Received Received
  P05-03 Homocysteine mediated oxidative stress is detrimental for pregnancy complications and outcome in Hepatitis E virus infected cases: A northeast Indian patients based study Diptika Tiwari Received Received
  P03-03 Lipid based Nanoparticulate system for effective vaccine delivery Priyanka Gosain Received Received
  P01-03 Antibody coated Liposomes for Transmucosal Vaccination Saurabh Bhargava Received Received
  P02-03 HCV treatment with DAA in children and adolescents in Russian Federation (single center study) Elena Egorova Received Received
  P06-03 A CRISPR/Cas9 screen to identify host factors required for the hepatitis E virus life cycle Noémie Oechslin Received Received
  P01-04 Prevalence of hepatitis C virus infection among men who have sex with men in Moscow Pavel Bogomolov Received Received
  P05-04 Potential usefulness of chicken egg yolk immunoglobulins for immunotherapy of hepatitis b Livia Villar Received Received
  P06-04 Hepatitis b virus x protein is required for viral gene expression, indirectly controls cccdna amplification and is dispensable for dna synthesis Amir Shlomai Received Received
  P04-04 After the achivement of sustained virological response by direct acting antivirals, does the age influence the recovery of the hepatic reserve? Yoshiyasu Karino Received Received
  P03-04 An undetected Hepatitis C outbreak preceded the 2011 HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study Ilias Gountas Received Received
  P02-04 hepatitis b infection: is it a real public health threat in upper Egypt? Mahmoud S. Elzalabany Received Received
  P03-05 The impact of treatment emerging resistance associated substitution on outcomes of re-treatment using new generation HCV treatments: Nation-wide real world analysis Yael Gozlan Received Received
  P02-05 Clinicopathologic Characteristics of Follicular Lymphoma in Hepatitis C Virus-Infected Patients Harrys Torres Received Received
  P01-05 health-related quality of life evaluation using questionnaires in patients with chronic hepatitis c virus infection before receiving direct-acting antivirals treatment Raluca Dirtu Received Received
  P05-05 Molecular analysis of HCV subtype 1a dispersal patterns among inmates in Greece: HCV transmissions are not related to incarceration Evangelia-Georgia Kostaki Received Received
  P06-05 Type I interferon exposure augments follicular T helper cell phenotype and functionality Katharina Zoldan Received Received
  P06-06 Prospective study of HBV cccDNA kinetics in a French multicenter cohort of liver transplant patients (ECOGREFFE) reveals very early graft infection despite NUCHBIG prophylaxis Franois Villeret Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
04:46
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Translational research in viral hepatitis: Addressing the gaps for cure

 

23-25 January,2020 Athens
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 23/01/2020 TO 23/01/2021
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                  
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 22/01/2020
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video




PosterSessionOnline
Logo Draft
 
Logo Cert